menu
    • menu

    Company profile for Exo Therapeutics

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightTM platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect. Through this spec...
    Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightTM platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect. Through this specific and selective approach to challenging targets, the company’s team of world-class researchers is unlocking breakthrough therapeutics in oncology, inflammation and a broad range of other diseases

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Exo TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    325 Vassar St, Cambridge, Massachusetts 02139, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://exo-therapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/exorx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Exo Therapeutics Announces Poster At ACR Convergence
    Exo Therapeutics Announces Poster At ACR Convergence

    22 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241022136486/en

    BUSINESSWIRE
    22 Oct 2024
    Share Share
    Exo Therapeutics Presents TBK1/STING Inhibitor Data At FOCIS 2024
    Exo Therapeutics Presents TBK1/STING Inhibitor Data At FOCIS 2024

    20 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240620886033/en

    BUSINESSWIRE
    20 Jun 2024
    Share Share
    Exo Announces Lead Program, Targeting TANK Binding Kinase 1
    Exo Announces Lead Program, Targeting TANK Binding Kinase 1

    23 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230523005343/en

    BUSINESSWIRE
    23 May 2023
    Share Share
    Exo Therapeutics Appoints Nagesh Mahanthappa as Executive Chair
    Exo Therapeutics Appoints Nagesh Mahanthappa as Executive Chair

    04 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230104005160/en

    BUSINESSWIRE
    04 Jan 2023
    Share Share
    Exo Tx Appoints Stephanos Ioannidis as Exec VP and Catherine Scholz as Senior VP
    Exo Tx Appoints Stephanos Ioannidis as Exec VP and Catherine Scholz as Senior VP

    17 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220517005248/en

    BUSINESSWIRE
    17 May 2022
    Share Share
    Exo Appoints Dorothy Lou Bailey as Senior VP Corporate Development and Strategy
    Exo Appoints Dorothy Lou Bailey as Senior VP Corporate Development and Strategy

    26 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211026005126/en

    BUSINESSWIRE
    26 Oct 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search